Biotechnology company developing genetic medicines through precision RNA delivery
Biotechnology company developing genetic medicines through precision RNA delivery. Its proprietary lipid nanoparticle (LNP) platform uses rational lipid design and high-throughput discovery to selectively deliver RNA to tissues and cells beyond the liver, supporting a pipeline of in vivo CAR-T therapies for autoimmune disease and RNA treatments for chronic kidney disease.